A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in reducing the lesion size of dorsal wrist ganglion in adults - Nil

D. N. De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Patients diagnosed with wrist ganglion (ICD-11 Code FB42.2) clinically and by USG.
•2. Age 18- 65 years
•3. Participants of either sex or transgender
•4. Participants having prior experience or knowledge of the treatment. e.g. primed to expect homoeopathic aggravation and available treatment options for the disease conditions, intimated through Patient Information Sheet

•1. Not providing written informed consent of participation.
•2. Non-ambulant patients.
•3. Patient suffering from active or chronic, systemic or local infection or disease.
•4. Patients who are too sick for consultation.
•5. Unwilling to take part and not giving consent to join the study
•6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life.
•7. Pregnancy, puerperal women and lactating mother.
•8. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool) [21].
•9. Self-reported immune-compromised state, AIDS, hepatitis etc.
•10. Undergoing homoeopathic treatment for any chronic disease within last 6 months.
•11. Simultaneous participation in any other clinical trial.

发起方

D. N. De Homoeopathic Medical College and Hospital